Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function

被引:15
作者
Chung, T. [1 ]
Lim, W-C [2 ]
Sy, R. [1 ]
Cunningham, I. [2 ]
Trotman, J. [2 ]
Kritharides, L. [1 ]
机构
[1] Univ Sydney, Concord Hosp, Dept Cardiol, Concord, NSW 2139, Australia
[2] Univ Sydney, Concord Hosp, Dept Haematol, Concord, NSW 2139, Australia
关键词
D O I
10.1136/hrt.2007.123299
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objective: To investigate subacute cardiac toxicity in patients with normal baseline cardiac function following autologous haematopoietic stem cell transplantation. Design: Prospective observational study. Patient and methods: Thirty-two consecutive patients (mean (SD) age 60 (11) years) with normal left ventricular ejection fraction (LVEF >= 50%) undergoing autologous haematopoietic stem cell transplantation were studied. Transthoracic echocardiography (including colour tissue Doppler imaging-derived myocardial velocities, strain and strain rates), troponin-T and B-type natriuretic peptide (BNP) and clinical details were recorded at baseline, after conditioning chemotherapy and serially over 6 weeks from the day of transplantation. Results: The mean (SD) LVEF at baseline was 62 (6)% and decreased to 55 (16)%, 6 weeks after transplantation (p = 0.007). Cardiac toxicity (>= 10% absolute decline of LVEF to an LVEF <= 50%) developed in 10 (31%) patients within 17 (8) days of transplantation and was usually reversible. In these 10 patients, the nadir LVEF was 39 (12)%. Two patients developed severe clinical pulmonary oedema, one episode of which was fatal. Troponin-T was mildly raised in only three of the patients with cardiac toxicity. Peak BNP values were similar in patients with or without post-transplant cardiac toxicity (149 (100) vs 196 (178) pg/ml, p = 0.43). Multivariate Cox proportional hazard regression identified baseline mitral annular systolic velocity as the only independent predictor of cardiac toxicity (hazard ratio 0.42, 95% confidence interval 0.20 to 0.86, p = 0.02). Conclusion: Subacute cardiac toxicity is common after autologous haematopoietic stem cell transplantation, even in patients with apparently normal left ventricular function. Anticipation of the period of greatest risk and recognition of patients with subclinical myocardial dysfunction may prevent clinical heart failure.
引用
收藏
页码:911 / 918
页数:8
相关论文
共 32 条
[1]
Reversible myocardial dysfunction in critically ill, noncardiac patients:: A review [J].
Bailén, MR .
CRITICAL CARE MEDICINE, 2002, 30 (06) :1280-1290
[2]
Benvenuto Giuseppe Marino, 2003, Ital Heart J, V4, P655
[3]
Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy [J].
Cardinale, D ;
Sandri, MT ;
Colombo, A ;
Colombo, N ;
Boeri, M ;
Lamantia, G ;
Civelli, M ;
Peccatori, F ;
Martinelli, G ;
Fiorentini, C ;
Cipolla, CM .
CIRCULATION, 2004, 109 (22) :2749-2754
[4]
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition [J].
Cardinale, Daniela ;
Colombo, Alessandro ;
Sandri, Maria T. ;
Lamantia, Giuseppina ;
Colombo, Nicola ;
Civelli, Maurizio ;
Martinelli, Giovanni ;
Veglia, Fabrizio ;
Fiorentini, Cesare ;
Cipolla, Carlo M. .
CIRCULATION, 2006, 114 (23) :2474-2481
[5]
Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study [J].
Chung, T. ;
Kelleher, S. ;
Liu, P. Y. ;
Conway, A. J. ;
Kritharides, L. ;
Handelsman, D. J. .
CLINICAL ENDOCRINOLOGY, 2007, 66 (02) :235-245
[6]
Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department [J].
Chung, Tommy ;
Sindone, Andrew ;
Foo, Fiona ;
Dwyer, Andrew ;
Paoloni, Richard ;
Janu, Margaret R. ;
Wong, Helen ;
Hall, Judith ;
Freedman, Saul B. .
AMERICAN HEART JOURNAL, 2006, 152 (05) :949-955
[7]
Medical progress: Hematopoietic stem-cell transplantation [J].
Copelan, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (17) :1813-1826
[8]
Eguchi Y, 1997, CANCER RES, V57, P1835
[9]
CARDIOTOXICITY ASSOCIATED WITH HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY [J].
GOTTDIENER, JS ;
APPELBAUM, FR ;
FERRANS, VJ ;
DEISSEROTH, A ;
ZIEGLER, J .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (06) :758-763
[10]
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751